Sources: Huawei aims to produce ~600K of its marquee 910C Ascend chips in 2026, roughly double 2025's level, and raise its Ascend lineup output to 1.6M dies
Context & Ripple Effects
Huawei had previously targeted mass production of the Ascend 910C while contending with supply limits tied to US restrictions. This new output target turns that product plan into a capacity test.
The expansion is notable because earlier reporting said Huawei's next Ascend designs would remain on a 7nm-based architecture through at least 2026, making manufacturing scale central to its AI-chip strategy.
First-order effects
- Huawei is setting a 2026 goal of roughly 600,000 flagship 910C chips and 1.6 million Ascend dies overall, raising the volume available to its AI-compute customers if production meets plan.
- The target increases pressure on Huawei's chip-production and packaging chain to deliver more usable dies despite the constraints that had limited earlier 910C supply.
Second-order effects
- Chinese buyers seeking domestic AI hardware would have a larger potential supply base, reducing the extent to which access to Huawei accelerators is governed by scarcity alone.
- Huawei's manufacturing partners and component suppliers would need to prioritize yield, packaging, and input availability; shortfalls in any of those areas could constrain the announced volume plan.
Third-order effects
- If sustained, higher Ascend output would make domestic compute capacity a more credible second source for Chinese AI deployments, even where Huawei trails leading-edge process technology.
- The story underscores an AI-hardware competition increasingly shaped by manufacturing resilience and available volume, not only by chip-design performance.
The trend: China's AI-chip market is moving from isolated domestic alternatives toward an effort to build scalable, supply-constrained compute ecosystems.